Apr 18

TOBI Faculty Dr. Gerry Malanga, MD, Awarded Research Grant to Treat Active-Duty Military Personnel

Congratulations TOBI Faculty Gerry Malanga, for the new research grant you and your team were awarded to Treat Active-Duty Military Personnel. Dr. Gerard Malanga, MD, Dr. Trevor Dyson-Hudson, MD, Dr. Nathan Hogaboom, PhD, received a $590,000 award from the Geneva Foundation for the use of Autologous Micro-Fragmented Adipose Tissue to Treat Meniscal Injuries in Active-Duty Military Personnel. Knee injuries are common among active-duty military personnel. One of the most common knee injuries is a meniscus tear, which can have several...

Mar 8

Amniotic Fluid Products Probably Don’t Contain Stem Cells, but May Still Modulate Healing

In vivo amniotic fluid is known to contain growth factors and mesenchymal stem cells (MSCs), which prior research has suggested may aid in tissue healing. Several companies have injectable amniotic fluid products  (AFPs) on the market based on this  prior research, but it’s unclear exactly what the composition of these AFPs is and whether they contain viable MSCs that could participate in healing. To clarify these lingering questions, upcoming TOBI conference speaker Dr. Panero and several of his colleagues at...

Jan 20

The Influence of Naproxen on Biological Factors in Leukocyte-Rich PRP: A Prospective Study

Chahla et al 2019 (NSAIDS) Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) consists of blood plasma with higher concentrations of platelets and leukocytes than typically available in a normal blood draw, and is commonly used to treat musculoskeletal injuries through regenerative processes in the body.  Oftentimes, concentrations of platelets and leukocytes are highly variable in a given therapeutic sample, as well as the methods of preparing that biological product and the demographic characteristics from which the blood sample was drawn. All these factors,...